reference/18921021

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18921021

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	806
issn	1568-0096
issueIdentifier	10
pageRange	796-806
publicationName	Current Cancer Drug Targets
startingPage	796
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb81359e45bfca641d8b8d37f398daa5 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3a69d0ff3dd5444a4b1c4acfb80df654 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6e646f34617ad5d709d21eacce7a6015 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e07d1397b83c0a24f78e45eea10c97ca http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5d82238aadc6875d4535828c68a827fb
bibliographicCitation	Wu Y, He Z, Li S, Tang H, Wang L, Yang S, Dong B, Qin J, Sun Y, Yu H, Zhang Y, Zhang Y, Guo Y, Wang Q. Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells. Curr Cancer Drug Targets. 2019;19(10):796–806. doi: 10.2174/1568009619666190103122735. PMID: 30605061.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e00e84f368a4c3b47b34297a9a3ee70f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae4fd5d9e7e4f8c041dca0f10a5048a8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2746d07f356431af29df5a18982e67a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d2ed528a1b6bc64ba4fbdad4b81cb606 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fbe3ea903f3d11865fd4868f2efd662 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfcd218d4584aaceaf94527eeb689ca6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8f8f763037f2731664644d6e7d6e204 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_199ab9dc7e2da1c3e2660d6904fe5670 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1641-2969 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2008-6193 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32ea661f3df53f62c681454a02d5c40d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f7b8759c6fd560b22e9f0103520d7ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f48f74bcd2ca2bd0c46c47f8b3031e85 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6b596d570ea20304f3bd04489e17667 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0510-0388 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0982-7584 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5f1737ecfad11c164fbd1f132cb0924 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_711d1064d1be6d2c841194d4322bbb44
date	2019-12-23^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/30605061 https://doi.org/10.2174/1568009619666190103122735
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/29993 https://portal.issn.org/resource/ISSN/1568-0096
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells
discusses	http://id.nlm.nih.gov/mesh/M0023900 http://id.nlm.nih.gov/mesh/M0023875 http://id.nlm.nih.gov/mesh/M0457719 http://id.nlm.nih.gov/mesh/M0021788 http://id.nlm.nih.gov/mesh/M0485644 http://id.nlm.nih.gov/mesh/M0211005 http://id.nlm.nih.gov/mesh/M0444984 http://id.nlm.nih.gov/mesh/M0495016 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0445927
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015972Q000187 http://id.nlm.nih.gov/mesh/D050794Q000037 http://id.nlm.nih.gov/mesh/D053612Q000037 http://id.nlm.nih.gov/mesh/D018277Q000188 http://id.nlm.nih.gov/mesh/D000077156Q000494 http://id.nlm.nih.gov/mesh/D015514Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D015514Q000378 http://id.nlm.nih.gov/mesh/D015534Q000378 http://id.nlm.nih.gov/mesh/D018277Q000473 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D014157Q000378 http://id.nlm.nih.gov/mesh/D015398 http://id.nlm.nih.gov/mesh/D014157Q000235 http://id.nlm.nih.gov/mesh/D014408Q000378 http://id.nlm.nih.gov/mesh/D015534Q000235 http://id.nlm.nih.gov/mesh/D014408Q000235 http://id.nlm.nih.gov/mesh/D018277Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1e096a68dc17fc518895c0ccda13eb97 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_54e32599939667ce8030f6c1725ceac0 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_17f32aee125cfd94e90fe691ef11a1e8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10188 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Showing number of triples: 1 to 80 of 80.